The largest database of trusted experimental protocols

12 protocols using cd24 percp cy5

1

Chordoma Cell Phenotype Changes by IFN-γ

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the effect of IFN-γ on the cell-surface phenotype of chordoma cells, cells were untreated or treated with 50 ng/mL of IFN-γ (R&D Systems, Minneapolis, MN) for 24 h. Cells were then harvested and stained with the following antibodies: HLA-ABC-FITC (BD Biosciences, San Jose, CA), PD-L1-APC (clone 29E.2A3; BioLegend, San Diego, CA), CD133-PE (Miltenyi Biotec, San Diego, CA), CD24-PerCP-Cy 5.5 (BD Biosciences), CD15-V450 (BD Biosciences), and ALDHA1-FITC (USBiological, Salem, MA). Cell viability was examined using far red fluorescent reactive dye (Thermo Fisher, Waltham, MA). Cells were incubated with the antibodies for 30 min at 4°C, acquired on a FACSCalibur flow cytometer or FACSVerse (Becton Dickinson, Franklin Lakes, NJ), and analyzed using FlowJo software (TreeStar, Inc., Ashland, OR). Isotype control staining was < 5% for all samples analyzed.
+ Open protocol
+ Expand
2

Characterization of PBMC Immune Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC from the WIHS repository were thawed and incubated for 48 hours and during the final 5 hours of incubation the cultures were supplemented with Brefeldin A (1:100, BD), PMA (50ng/ml, Invivogen) and Ionomycin (1ug/ml, Invivogen). The cells were washed, stained for viable cells (LIVE/DEAD Aqua Fixable Dead Cell Stain Kit, Invitrogen), surface stained, fixed/permeabilized (Fix/Perm Kit BD Biosciences) and stained for intracellular AID-PerCP (IC39101C, RnD System). The following antibodies were used for immunophenotyping of PBMC: CD19-ECD (IM2708U, Beckman Coulter), CD86-AF-700, CD10-PE-Cy7, CD4-Pacific Blue, CD127-APC-H7, CD71-FITC, CD38-PE, CD25-PE, CD24-PercpCy5.5 (all antibodies were purchased from BD Biosciences except when stated otherwise). All samples were acquired on an LRSII (BD, Bioscience) flow cytometer and the data were analyzed using FlowJo software (Tree Star Inc).
+ Open protocol
+ Expand
3

Comprehensive Antibody Characterization for EMT Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zyxin antibody was from Santa Cruz (sc‐293448) at 1:250 dilution for WB, 1:100 dilution for IF). The following antibodies were from Cell Signaling Technology: ZEB1 (3396S, 1:1000 dilution for WB), GAPDH (2118S, 1:5000 dilution for WB), E‐Cadherin (14472S, 1:1000 dilution for WB, 1:100 dilution for IF), vimentin (5741S, 1:1000 dilution for WB, 1:100 dilution for IF), CD44 (3570S, 1:300 dilution for immunohistochemistry [IHC]), 1:400 dilution for IF), SIRT1 (8469S, 1:1000 dilution for WB, 1:100 dilution for IP), 1:100 dilution for IF), HA‐Tag (3724S, 1:50 dilution for IP), anti‐mouse IgG (HRP‐linked, 7076S, 1:5000 dilution for WB), anti‐rabbit IgG (HRP‐linked, 7074S, 1:5000 dilution for WB). CD44‐PE (550989, 1:50 dilution for FCM) and CD24‐PerCP‐Cy5.5 (561647, 1:50 dilution for FCM) were from BD; CD24 (ab202073, 1:100 dilution for IF), H3 K9 (ab4441, 1:10000 dilution for WB), H3 K14 (ab82501, 1 mg/mL for WB), H3 K23 antibody (ab177275, 1:1000 dilution for WB), H3 K27 Antibody (ab4729, 1 μg/mL for WB), and H3 (ab47915, 1:1000 for WB) were from Abcam. Alexa Fluor 488 goat anti‐mouse IgG1 (A21121, 1:500 dilution for IF), Alexa Fluor 488 goat anti‐mouse IgG(H+L) (A11001, 1:500 dilution for IF), Alexa Fluor 568 goat anti‐rabbit IgG(H+L) (A11010, 1:500 dilution for IF), and Alexa Fluor 568 goat anti‐mouse IgG2a (A21134, 1:500 dilution for IF) were from Thermo Fisher Scientific.
+ Open protocol
+ Expand
4

Immunophenotyping of B cell subsets in severe asthma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque (GE Healthcare, Marolles-en-Hurepoix, France) gradient centrifugation and frozen. Immunophenotyping of PBMCs from 9 severe asthmatic patients was performed using flow cytometry. PBMCs from 10 HV were analyzed as controls. PBMCs were rapidly thawed by placing cryovials at 37°C, washed and stained according to standard protocols using the following mAbs: CD19-BUV395, CD27-BUV737, CD38-BV605, CD24-PerCP-Cy5.5, and CD9-BV510 (BD Biosciences, Le Pont de Claix, France). These markers were used to distinguish CD19+ B lymphocytes, CD19+CD27+ memory cells, CD19+CD27 naïve cells, CD19+CD24hiCD38hi transitional cells, CD19+CD24CD38+ plasma cells, and CD19+CD9+ Bregs. For all experiments, dead cells were excluded using the Zombie NIR™ Fixable Viability kit (BioLegend, London, UK). Human anti–IL-10 (BD Biosciences) was used to inhibit the IL-10 pathway. Samples were assessed on a BD LSRFORTESSA X-20 (BD Biosciences, Le Pont de Claix, France), and the data were analyzed using FlowJo v10 software (FlowJo LLC, Ashland, OR, USA).
+ Open protocol
+ Expand
5

Isolation and Characterization of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy individuals homozygous for the FcγRIIB-T232 or FcγRIIB-I232 site, under appropriate ethics approval from the NIHR Cambridge Bioresource. Inclusion criteria for individuals were people aged between 44 and 77 years, with no serious co-morbidities, no direct family history of autoimmune disease, no use of immunosuppressants or steroids and no hospitalisation within the last 12 months. Individuals were age and sex matched (18 females and 11 males matched between genotypes). Flow sorting was performed using CD19-BV785, CD38-BV711, CD3-NC650, CD14-605NC, CD24-PerCP-Cy5.5, IgD-FITC, CD27-PE-Cy7 (all from BD Bioscience) and Aqua (for live-dead cell detection, Invitrogen), where flow protocol is outlined in Supplementary Fig. 7.
+ Open protocol
+ Expand
6

Quantifying CD44+/CD24- Expression under Hypoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions for flow cytometry were achieved by passing the cells through a 40 μm cell strainer (BD Falcon, BD Biosciences, Franklin Lakes, NJ, USA) and staining with CD44-APC (#559942) and CD24-PerCP-Cy5.5 (#561647) from BD Pharmingen in Hanks’ buffer supplemented with 2% fetal bovine serum (FBS) according to the manufacturer’s instructions. All stained cells were run in a BD FACS Canto II (BD Biosciences, San Jose, CA, USA), and data were analyzed using FCS Express 5.0 software (De Novo Software, Glendale, CA, USA). To assess the changes in the expression of CD44+/CD24 under hypoxia, as compared to normoxia, gates were first established for positivity stained normoxic cells with antibodies of CD44 and CD24 using unstained normoxic cells as a negative control. Then, the stained normoxic group was chosen as a control and the same gating was adopted to measure the expression of CD44+/CD24 in hypoxic cells or other treatments.
+ Open protocol
+ Expand
7

Comprehensive B-Cell and cTfh Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
B‐cell subsets and cTfh were characterized using following surface markers: CD19‐FITC (Fluorescein isothiocyanate; Clone J4.119, Beckman Coulter, Indianapolis, IN, USA), CD38‐APC (Allophycocyanin; Clone HB‐7, BD Biosciences, San Jose, CA, USA), CD24‐PerCP‐Cy5.5 (Peridinin chlorophyll protein complex‐cyanine 5.5; Clone ML5, BD Biosciences), CD27‐PE (phycoerythrin; Clone L128, BD Biosciences), CD4‐PC7 (PE‐Cyanine7; Clone 13B8.2, Beckman Coulter), CXCR5‐ Alexa Fluor®488 (Clone RF8B2, BD Biosciences), PD‐1‐PerCP‐Cy5.5 (Clone EH12.1, BD Biosciences), and ICOS‐APC (Clone ISA‐3, BD Biosciences). The gating strategy of B‐cell subsets is shown in Supplementary Figure 1, while that of cTfh is shown in Supplementary Figure 2.
+ Open protocol
+ Expand
8

Flow Cytometry Analysis of Irradiated Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 96 h post-irradiation, tumor cells were examined by flow cytometry, as previously described [13 (link)]. Cells were examined on FACSCalibur or FACSVerse cytometers, using the monoclonal antibodies targeting HLA-ABC-FITC, HLA-ABC-PE-Cy7, ICAM-1 (CD54)-PE, CEA (CD66)-FITC, MUC-1 (CD227)-FITC, CD24-PerCP-Cy5.5, CD44-FITC, and the appropriate isotype-matched controls (BD Biosciences, San Jose, CA). The monoclonal antibodies targeting CD70-FITC, CD275 (ICOSL)-PE, CD137L (4-1BBL)-PE, CD252 (OX40L)-PE, PD-L1 (CD274)-PE, CTLA-4 (CD152)-PE, and CD227 (MUC-1)-PE were obtained from BioLegend (San Diego, CA). Antibodies targeting CD133-APC (Miltenyi Biotec, San Diego, CA) and calreticulin-PE (R&D Systems, Minneapolis, MN) were also used. Isotype control staining was < 5% for all samples analyzed. Viability was examined using LIVE/DEAD Fixable Violet Dead Stain Kit (Thermo Fisher Scientific, Rockville, MD). Cell surface expression was evaluated on live cells gated by FSC/SSC and LIVE/DEAD staining.
+ Open protocol
+ Expand
9

CD24 and CD44 Expression Analysis in Morphine-Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate CD24 and CD44 expression, cells were cultured with morphine (10 μM) for 14 days. Cells (2 × 106) were harvested and incubated with antibodies against CD44 FITC (BD Pharmingen) and CD24 PerCP-Cy5.5 (BD Pharmingen) for 30 minutes at 4°C in the dark. Unbound antibody was washed away through two cycles of washing with PBS. Then cells were analyzed on a BD FACS Calibur flow cytometer. These data were analyzed by Cellquest Pro and at least 20,000 events per sample were collected.
+ Open protocol
+ Expand
10

Single Cell Isolation for FACS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions for FACS and flow cytometry are achieved by passing cells through 40 μm cell stainer (BD Falcon) and staining with CD44-APC (#559942) and CD24-PerCP-Cy5.5 (#561647) from BD Pharmingen in Hanks' buffer supplemented with 2% FBS. Cells were collected in Hanks' buffer supplemented with 50% FBS.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!